The management of superficial bladder cancer
Open Access
- 1 January 2001
- journal article
- review article
- Published by Wiley in BJU International
- Vol. 87 (2) , 135-140
- https://doi.org/10.1046/j.1464-410x.2001.00948.x
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- RESULTS OF A RANDOMIZED PHASE III TRIAL OF SEQUENTIAL INTRAVESICAL THERAPY WITH MITOMYCIN C AND BACILLUS CALMETTE-GUERIN VERSUS MITOMYCIN C ALONE IN PATIENTS WITH SUPERFICIAL BLADDER CANCERJournal of Urology, 1998
- Long‐term survival of patients with bladder tumours: the significance of risk factorsBritish Journal of Urology, 1998
- Is Routine Excretory Urography Necessary at First Diagnosis of Bladder Cancer?Journal of Urology, 1997
- Factors affecting recurrence and progression in superficial bladder tumoursEuropean Journal Of Cancer, 1995
- Original Articles: Bladder Cancer: Intravesical Adjuvant Chemotherapy for Superficial Transitional Cell Bladder Carcinoma: Results of 2 European Organization for Research and Treatment of Cancer Randomized Trials With Mitomycin C and Doxorubicin Comparing Early Versus Delayed Instillations and Short-Term Versus Long-Term TreatmentJournal of Urology, 1995
- Original Articles: Bladder Cancer: A Randomized Study of Intravesical Mitomycin C, Bacillus Calmette-Guerin Tice and Bacillus Calmette-Guerin RIVM Treatment in pTa-pT1 Papillary Carcinoma and Carcinoma in Situ of the BladderJournal of Urology, 1995
- Low‐dose bacille Calmette‐Guerin (BCG) therapy in superficial high‐risk bladder cancer: a phase II study with the BCG strain Connaught CanadaBritish Journal of Urology, 1995
- Der Wert der transurethralen Nachresektion beim oberflächlichen HarnblasenkarzinomAktuelle Urologie, 1994